Oncology & Cancer

Promising new pancreatic cancer treatment moves forward

Even among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progress has lagged behind that of many other malignancies.

Oncology & Cancer

Major pancreatic cancer breakthrough

Clinical trial results presented today at a prestigious cancer meeting in Chicago show substantial increased survival rates for pancreatic cancer patients who received a four-drug chemotherapy combination known as mFOLFIRINOX ...

Oncology & Cancer

Researchers 'turn off' most notorious cancer-causing protein

It's known as the most common cancer-causing protein, directly responsible for 30 per cent of all cancers and indirectly involved in virtually all cancers. For over 30 years, scientists have failed to successfully target ...

Oncology & Cancer

Pancreatic cancer: Aggressive behavior from the start

Pancreatic cancer is regarded as the cancer type with the lowest survival rates. Fewer than seven in 100 patients survive the first five years after diagnosis. Clinicians attribute this devastating prognosis to two circumstances: ...

page 3 from 40